Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Rotavirus vaccines: an overview.

Dennehy PH.

Clin Microbiol Rev. 2008 Jan;21(1):198-208. doi: 10.1128/CMR.00029-07. Review.

2.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
3.
4.

Rotavirus vaccines--an update.

Dennehy PH.

Vaccine. 2007 Apr 20;25(16):3137-41. Epub 2007 Feb 9. Review.

PMID:
17321017
5.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799
6.

Clinical trials of rotavirus vaccines in Europe.

Vesikari T, Giaquinto C, Huppertz HI.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S42-7. Review.

PMID:
16397428
7.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
8.

Rotavirus vaccines.

Vesikari T.

Scand J Infect Dis. 2008;40(9):691-5. Review.

PMID:
19086243
9.

Rotavirus vaccines: an update.

Dennehy PH.

Curr Opin Pediatr. 2005 Feb;17(1):88-92. Review.

PMID:
15659970
10.

Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.

Lepage P, Vergison A.

Expert Opin Biol Ther. 2007 Dec;7(12):1881-92. Review.

PMID:
18034653
11.

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F.

Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Review.

PMID:
20006144
12.

Rotavirus vaccines: entering a new stage of deployment.

Nakagomi O, Cunliffe NA.

Curr Opin Infect Dis. 2007 Oct;20(5):501-7. Review.

PMID:
17762784
13.

Rotavirus vaccine: early introduction in Latin America-risks and benefits.

Pérez-Vargas J, Isa P, López S, Arias CF.

Arch Med Res. 2006 Jan;37(1):1-10. Review.

PMID:
16314179
14.

Characteristics of an ideal rotavirus vaccine.

Reisinger KS, Block SL.

Clin Pediatr (Phila). 2008 Jul;47(6):555-63. doi: 10.1177/0009922808314903. Epub 2008 May 8.

PMID:
18467670
15.

Rotavirus vaccination: a concise review.

Vesikari T.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:57-63. doi: 10.1111/j.1469-0691.2012.03981.x. Epub 2012 Aug 6. Review.

16.

RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.

Chandran A, Santosham M.

Expert Rev Vaccines. 2008 Dec;7(10):1475-80. doi: 10.1586/14760584.7.10.1475. Review.

PMID:
19053204
17.

Live attenuated human rotavirus vaccine, Rotarix.

Bernstein DI.

Semin Pediatr Infect Dis. 2006 Oct;17(4):188-94. Review.

PMID:
17055369
18.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team..

N Engl J Med. 2006 Jan 5;354(1):23-33.

19.

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Clark HF, Offit PA, Plotkin SA, Heaton PM.

Pediatr Infect Dis J. 2006 Jul;25(7):577-83. Review.

PMID:
16804425
20.

The future of rotavirus vaccines.

Offit PA.

Semin Pediatr Infect Dis. 2002 Jul;13(3):190-5. Review.

PMID:
12199615

Supplemental Content

Support Center